COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH REAL-WORLD TREATMENT FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION IN CHINA

被引：0
|
作者：
Yang, L. [1 ]
Wu, J. [2 ]
机构：
[1] Peking Univ, Beijing, Peoples R China
[2] Bayer Healthcare Co Ltd, Beijing, Peoples R China
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.381
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV60
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Kapur, A. K.
    Chatzitheofilou, I
    Schang, L. K.
    VALUE IN HEALTH, 2012, 15 (04) : A122 - A122
  • [22] Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
    Lee, Soyon
    Anglade, Moise W.
    Dan Pham
    Pisacane, Robyn
    Kluger, Jeffrey
    Coleman, Craig I.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06): : 845 - 851
  • [23] Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
    Rognoni, Carla
    Marchetti, Monia
    Quaglini, Silvana
    Liberato, Nicola Lucio
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (02) : 149 - 154
  • [24] Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
    Carla Rognoni
    Monia Marchetti
    Silvana Quaglini
    Nicola Lucio Liberato
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 149 - 154
  • [25] A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
    Pinyol C.
    Cepeda J.M.ª
    Roldan I.
    Roldan V.
    Jimenez S.
    Gonzalez P.
    Soto J.
    Cardiology and Therapy, 2016, 5 (2) : 171 - 186
  • [26] REAL-WORLD DATA COST-EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS COMPARED WITH ACENOCOUMAROL FOR THE MANAGEMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN SPAIN
    Gorostiza, I
    Bilbao, A.
    Mar, J.
    VALUE IN HEALTH, 2024, 27 (12) : S68 - S68
  • [27] Cost-effectiveness of anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation in mainland China
    Zhou, Hui
    Nie, Xiaoning
    Jiang, Minghuan
    Dong, Weihua
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (04) : 523 - 530
  • [28] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [29] Dabigatran in 'real-world' clinical practice for stroke prevention in patients with non-valvular atrial fibrillation
    Potpara, Tatjana S.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1093 - 1098
  • [30] Real - world evidence of stroke prevention in patients with non-valvular atrial fibrillation
    Coleman, C.
    Antz, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 502 - 502
12345